Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients.
C M Nijenhuis
,
A D R Huitema
,
C Blank
,
J B A G Haanen
,
J V van Thienen
,
H Rosing
,
J H M Schellens
,
J H Beijnen
More about this publication
Journal of clinical pharmacology
Volume
57
Issue nr.
1
Pages
125-128
Publication date
01-01-2017
Full text links
Publisher website (DOI)
10.1002/jcph.788
Europe PubMed Central
27365214
Pubmed
27365214